258 related articles for article (PubMed ID: 34132026)
1. PU.1 inhibition attenuates atrial fibrosis and atrial fibrillation vulnerability induced by angiotensin-II by reducing TGF-β1/Smads pathway activation.
Hu J; Zhang JJ; Li L; Wang SL; Yang HT; Fan XW; Zhang LM; Hu GL; Fu HX; Song WF; Yan LJ; Liu JJ; Wu JT; Kong B
J Cell Mol Med; 2021 Jul; 25(14):6746-6759. PubMed ID: 34132026
[TBL] [Abstract][Full Text] [Related]
2. MFGE8 attenuates Ang-II-induced atrial fibrosis and vulnerability to atrial fibrillation through inhibition of TGF-β1/Smad2/3 pathway.
Ge Z; Chen Y; Wang B; Zhang X; Yan Y; Zhou L; Zhang Y; Xie Y
J Mol Cell Cardiol; 2020 Feb; 139():164-175. PubMed ID: 31958465
[TBL] [Abstract][Full Text] [Related]
3. Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor-specific Arkadia-mediated downregulation of Smad7.
He X; Gao X; Peng L; Wang S; Zhu Y; Ma H; Lin J; Duan DD
Circ Res; 2011 Jan; 108(2):164-75. PubMed ID: 21127293
[TBL] [Abstract][Full Text] [Related]
4. LOXL2 Inhibitor Attenuates Angiotensin II-Induced Atrial Fibrosis and Vulnerability to Atrial Fibrillation through Inhibition of Transforming Growth Factor Beta-1 Smad2/3 Pathway.
Wu Y; Can J; Hao S; Qiang X; Ning Z
Cerebrovasc Dis; 2022; 51(2):188-198. PubMed ID: 34515064
[TBL] [Abstract][Full Text] [Related]
5. Neferine mitigates angiotensin II-induced atrial fibrillation and fibrosis via upregulation of Nrf2/HO-1 and inhibition of TGF-β/p-Smad2/3 pathways.
Jiang XX; Zhang R; Wang HS
Aging (Albany NY); 2024 May; 16(10):8630-8644. PubMed ID: 38775722
[TBL] [Abstract][Full Text] [Related]
6. FOXF1 ameliorates angiotensin II-induced cardiac fibrosis in cardiac fibroblasts through inhibiting the TGF-β1/Smad3 signaling pathway.
Jin D; Han F
J Recept Signal Transduct Res; 2020 Dec; 40(6):493-500. PubMed ID: 32496870
[TBL] [Abstract][Full Text] [Related]
7. Platelets Promote Ang II (Angiotensin II)-Induced Atrial Fibrillation by Releasing TGF-β1 (Transforming Growth Factor-β1) and Interacting With Fibroblasts.
Liu Y; Lv H; Tan R; An X; Niu XH; Liu YJ; Yang X; Yin X; Xia YL
Hypertension; 2020 Dec; 76(6):1856-1867. PubMed ID: 33175633
[TBL] [Abstract][Full Text] [Related]
8. Modulation of miR-10a-mediated TGF-β1/Smads signaling affects atrial fibrillation-induced cardiac fibrosis and cardiac fibroblast proliferation.
Li PF; He RH; Shi SB; Li R; Wang QT; Rao GT; Yang B
Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30683806
[TBL] [Abstract][Full Text] [Related]
9. Connective tissue growth factor expression after angiotensin II exposure is dependent on transforming growth factor-β signaling via the canonical Smad-dependent pathway in hypertensive induced myocardial fibrosis.
Wong CKS; Falkenham A; Myers T; Légaré JF
J Renin Angiotensin Aldosterone Syst; 2018; 19(1):1470320318759358. PubMed ID: 29575960
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of Transient Receptor Potential Canonical Type 3 Channel via AT1R/TGF-
He R; Zhang J; Luo D; Yu Y; Chen T; Yang Y; Yu F; Li M
Oxid Med Cell Longev; 2019; 2019():4025496. PubMed ID: 31871548
[TBL] [Abstract][Full Text] [Related]
11. The crucial role of activin A/ALK4 pathway in the pathogenesis of Ang-II-induced atrial fibrosis and vulnerability to atrial fibrillation.
Wang Q; Yu Y; Zhang P; Chen Y; Li C; Chen J; Wang Y; Li Y
Basic Res Cardiol; 2017 Jul; 112(4):47. PubMed ID: 28639003
[TBL] [Abstract][Full Text] [Related]
12. LncRNA PVT1 regulates atrial fibrosis via miR-128-3p-SP1-TGF-β1-Smad axis in atrial fibrillation.
Cao F; Li Z; Ding WM; Yan L; Zhao QY
Mol Med; 2019 Mar; 25(1):7. PubMed ID: 30894138
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3.
Yang F; Chung AC; Huang XR; Lan HY
Hypertension; 2009 Oct; 54(4):877-84. PubMed ID: 19667256
[TBL] [Abstract][Full Text] [Related]
14. Salidroside attenuates atrial fibrosis and atrial fibrillation vulnerability induced by angiotensin-II through inhibition of LOXL2-TGF-β1-Smad2/3 pathway.
Hai Z; Wu Y; Ning Z
Heliyon; 2023 Nov; 9(11):e21220. PubMed ID: 37920527
[TBL] [Abstract][Full Text] [Related]
15. Qishen granule attenuates cardiac fibrosis by regulating TGF-β /Smad3 and GSK-3β pathway.
Zeng Z; Wang Q; Yang X; Ren Y; Jiao S; Zhu Q; Guo D; Xia K; Wang Y; Li C; Wang W
Phytomedicine; 2019 Sep; 62():152949. PubMed ID: 31102891
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of microRNA-21 mediates Ang II-induced renal fibrosis by activating the TGF-β1/Smad3 pathway via suppressing PPARα.
Lyu H; Li X; Wu Q; Hao L
J Pharmacol Sci; 2019 Sep; 141(1):70-78. PubMed ID: 31611175
[TBL] [Abstract][Full Text] [Related]
17. Suppression of ADAM8 attenuates angiotensin II-induced cardiac fibrosis and endothelial-mesenchymal transition via inhibiting TGF-β1/Smad2/Smad3 pathways.
Yao L; Shao W; Chen Y; Wang S; Huang D
Exp Anim; 2022 Feb; 71(1):90-99. PubMed ID: 34615811
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA LICPAR regulates atrial fibrosis via TGF-β/Smad pathway in atrial fibrillation.
Wang H; Song T; Zhao Y; Zhao J; Wang X; Fu X
Tissue Cell; 2020 Dec; 67():101440. PubMed ID: 32971457
[TBL] [Abstract][Full Text] [Related]
19. COMP Improves Ang-II-Induced Atrial Fibrillation via TGF-β Signaling Pathway.
Cai X; Li M; Zhong Y; Yang W; Liang Z
Cardiovasc Toxicol; 2023 Oct; 23(9-10):305-316. PubMed ID: 37584842
[TBL] [Abstract][Full Text] [Related]
20. Endothelial nitric oxide synthase-independent protective action of statin against angiotensin II-induced atrial remodeling via reduced oxidant injury.
Yagi S; Akaike M; Aihara K; Ishikawa K; Iwase T; Ikeda Y; Soeki T; Yoshida S; Sumitomo-Ueda Y; Matsumoto T; Sata M
Hypertension; 2010 Apr; 55(4):918-23. PubMed ID: 20194307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]